Related Experiment Videos
[Mixed connective tissue disease in childhood. Report of a case]
Abstract:
The Authors report a case of MCTD in a 11 years old girl. Initially the disease presented the classical clinical picture of IDM. Successively its evolution was marked by the appearance of the typical clinical features of JRA, SS and of serum antibodies anti-RNP and by absence of antibodies anti-dsDNA and anti-Sm. These data are characteristic of MCTD. The occurrence of this disease in children is extremely rare and the prognosis is related to a possible renal and/or haemopoietic involvement.
Insights
This case study details a rare pediatric presentation of Mixed Connective Tissue Disease (MCTD) in an 11-year-old girl, highlighting its complex diagnostic evolution and potential complications.
Area of Science:
- Pediatric Rheumatology
- Autoimmune Diseases
- Clinical Case Reports
Background:
- Mixed Connective Tissue Disease (MCTD) is a rare autoimmune disorder.
- Pediatric MCTD is exceptionally uncommon, posing diagnostic challenges.
- Early identification is crucial for managing potential complications.
Observation:
- An 11-year-old girl initially presented with features suggestive of Idiopathic Disease of the Month (IDM).
- The disease evolved to exhibit characteristics of Juvenile Rheumatoid Arthritis (JRA) and Systemic Sclerosis (SS).
- Serological analysis revealed anti-RNP antibodies with an absence of anti-dsDNA and anti-Sm antibodies.
Findings:
- The clinical and serological profile confirmed a diagnosis of Mixed Connective Tissue Disease (MCTD).
- The patient's presentation underscores the varied and evolving nature of pediatric autoimmune conditions.
- The specific antibody profile (anti-RNP positive, anti-dsDNA/anti-Sm negative) is characteristic of MCTD.
Implications:
- This case highlights the rarity and diagnostic complexity of MCTD in children.
- Prognosis in pediatric MCTD is significantly influenced by the potential for renal and hematopoietic system involvement.
- Early and accurate diagnosis is vital for timely intervention and improved outcomes in pediatric MCTD.